| Literature DB >> 28684415 |
Maria Bakou1, Kathleen Hille1, Michael Kracklauer1, Anna Spanopoulou1, Christina V Frost2, Eleni Malideli1, Li-Mei Yan1, Andrea Caporale1, Martin Zacharias2, Aphrodite Kapurniotu3.
Abstract
The interaction of the intrinsically disordered polypeptide islet amyloid polypeptide (IAPP), which is associated with type 2 diabetes (T2D), with the Alzheimer's disease amyloid-β (Aβ) peptide modulates their self-assembly into amyloid fibrils and may link the pathogeneses of these two cell-degenerative diseases. However, the molecular determinants of this interaction remain elusive. Using a systematic alanine scan approach, fluorescence spectroscopy, and other biophysical methods, including heterocomplex pulldown assays, far-UV CD spectroscopy, the thioflavin T binding assay, transmission EM, and molecular dynamics simulations, here we identified single aromatic/hydrophobic residues within the amyloid core IAPP region as hot spots or key residues of its cross-interaction with Aβ40(42) peptide. Importantly, we also find that none of these residues in isolation plays a key role in IAPP self-assembly, whereas simultaneous substitution of four aromatic/hydrophobic residues with Ala dramatically impairs both IAPP self-assembly and hetero-assembly with Aβ40(42). Furthermore, our experiments yielded several novel IAPP analogs, whose sequences are highly similar to that of IAPP but have distinct amyloid self- or cross-interaction potentials. The identified similarities and major differences controlling IAPP cross-peptide interaction with Aβ40(42) versus its amyloid self-assembly offer a molecular basis for understanding the underlying mechanisms. We propose that these insights will aid in designing intervention strategies and novel IAPP analogs for the management of type 2 diabetes, Alzheimer's disease, or other diseases related to IAPP dysfunction or cross-amyloid interactions.Entities:
Keywords: Alzheimer disease; amyloid; amyloid-beta (AB); diabetes; islet amyloid polypeptide; peptide conformation; peptide interaction; protein aggregation; protein misfolding; protein-protein interaction
Mesh:
Substances:
Year: 2017 PMID: 28684415 PMCID: PMC5582850 DOI: 10.1074/jbc.M117.774893
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157